致：尼科letti F、孔杰特L、迪毛罗M等人（2002年）。新诊断的1型糖尿病患者和有患该病风险的受试者血清中干扰素-α诱导趋化因子IP-10/CXCL10的浓度均升高。《糖尿病学》45:1107 - 1110。 - Suppr

Suppr

超能文献

-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110.

作者信息

Rotondi M, Romagnani P, Brozzetti A, Santeusanio F, Serio M, Falorni A

出版信息

Diabetologia. 2003 Jul;46(7):1020-1. doi: 10.1007/s00125-003-1134-4. Epub 2003 Jun 18.

DOI:10.1007/s00125-003-1134-4

PMID:12819903

Abstract

摘要

相似文献

-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110.致：尼科letti F、孔杰特L、迪毛罗M等人（2002年）。新诊断的1型糖尿病患者和有患该病风险的受试者血清中干扰素-α诱导趋化因子IP-10/CXCL10的浓度均升高。《糖尿病学》45:1107 - 1110。

Diabetologia. 2003 Jul;46(7):1020-1. doi: 10.1007/s00125-003-1134-4. Epub 2003 Jun 18.

Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease.

Diabetologia. 2002 Aug;45(8):1107-10. doi: 10.1007/s00125-002-0879-5. Epub 2002 Jun 21.

Elevated serum IP-10 levels observed in type 1 diabetes.

Diabetes Care. 2001 Mar;24(3):510-5. doi: 10.2337/diacare.24.3.510.

Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.自身免疫性原发性肾上腺皮质功能减退症患者血清中干扰素-γ诱导趋化因子-10/CXC趋化因子配体-10水平升高以及促炎细胞因子刺激后人肾上腺细胞原代培养物中的体外表达。

J Clin Endocrinol Metab. 2005 Apr;90(4):2357-63. doi: 10.1210/jc.2004-1062. Epub 2005 Jan 18.

Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.慢性自身免疫性甲状腺炎患者血清中γ干扰素诱导的α趋化因子CXCL10水平升高，而β趋化因子CCL2水平未升高。

Eur J Endocrinol. 2005 Feb;152(2):171-7. doi: 10.1530/eje.1.01847.

Significance of serum CXCL10/IP-10 level in type 1 diabetes.

J Autoimmun. 2006 Feb;26(1):66-71. doi: 10.1016/j.jaut.2005.09.027. Epub 2005 Nov 23.

Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.干扰素-γ诱导的α趋化因子CXCL10参与格雷夫斯眼病：过氧化物酶体增殖物激活受体-γ激动剂的调节作用

J Clin Endocrinol Metab. 2006 Feb;91(2):614-20. doi: 10.1210/jc.2005-1689. Epub 2005 Nov 22.

IP-10 in atopic dermatitis.特应性皮炎中的IP-10

Allergy. 2003 Mar;58(3):261. doi: 10.1034/j.1398-9995.2003.00062_2.x.

Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.眼部结节病中，γ干扰素诱导的血清CXCL9/单核细胞趋化蛋白和CXCL10/γ干扰素诱导蛋白10水平升高。

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1063-8. doi: 10.1167/iovs.05-0966.

Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.在体内和体外，星形胶质细胞通过不依赖干扰素的方式，由人类免疫缺陷病毒1型gp120介导诱导CXCL10/IP-10基因表达。

J Virol. 2001 Aug;75(15):7067-77. doi: 10.1128/JVI.75.15.7067-7077.2001.

引用本文的文献

Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.趋化因子在 1 型糖尿病自身免疫破坏中的作用：考虑到最佳治疗方案，为治疗干预提供机会。

Front Endocrinol (Lausanne). 2020 Oct 19;11:591083. doi: 10.3389/fendo.2020.591083. eCollection 2020.

Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.大规模发现与验证研究表明，1型糖尿病患者循环中的白细胞介素8、白细胞介素-1受体拮抗剂、单核细胞趋化蛋白-1和巨噬细胞炎性蛋白-1β水平显著降低。

J Clin Endocrinol Metab. 2015 Sep;100(9):E1179-87. doi: 10.1210/JC.2015-1388. Epub 2015 Jul 9.

Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.在诊断后 1 年内，脂联素、白细胞介素 (IL)-1ra、诱导蛋白 10、IL-6 和胰岛自身抗体数量与 1 型糖尿病的进展模式相关。

Clin Exp Immunol. 2010 Sep;161(3):444-52. doi: 10.1111/j.1365-2249.2010.04193.x.

Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.新发病1型糖尿病儿童的CD4和CD8 T细胞表型受损及趋化因子分泌减少

Clin Exp Immunol. 2008 Sep;153(3):360-8. doi: 10.1111/j.1365-2249.2008.03720.x.

本文引用的文献

Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.γ干扰素诱导趋化因子在内分泌自身免疫中的作用：一个不断扩展的领域。

J Endocrinol Invest. 2003 Feb;26(2):177-80. doi: 10.1007/BF03345149.

Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease.

Diabetologia. 2002 Aug;45(8):1107-10. doi: 10.1007/s00125-002-0879-5. Epub 2002 Jun 21.

Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.IP-10/CXCL10和MIG/CXCL9在甲状腺中的表达以及初发Graves病患者血清中IP-10/CXCL10水平升高。

Am J Pathol. 2002 Jul;161(1):195-206. doi: 10.1016/S0002-9440(10)64171-5.

Elevated serum IP-10 levels observed in type 1 diabetes.

Diabetes Care. 2001 Mar;24(3):510-5. doi: 10.2337/diacare.24.3.510.

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.意大利2型糖尿病患者中，伴有谷氨酸脱羧酶65自身抗体者发生内分泌自身免疫的风险增加。

Clin Endocrinol (Oxf). 2000 May;52(5):565-73. doi: 10.1046/j.1365-2265.2000.00983.x.

IDDM and autoimmune thyroid disease in the pediatric age group.儿童年龄组中的胰岛素依赖型糖尿病和自身免疫性甲状腺疾病。

J Pediatr Endocrinol Metab. 1996 Mar;9 Suppl 1:89-94. doi: 10.1515/jpem.1996.9.s1.89.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验